In December, the U.S. Food and Drug Administration (FDA) confirmed that taking the type 2 diabetes drug pioglitazone, also known as Actos, can increase patients' risk of developing bladder cancer.
The FDA announced this conclusion in a drug safety communication,… Read More
After 9,000 lawsuits having been filed against them, Takeda Pharmaceutical Co. has agreed to pay $2.37 billion to resolve claims that the popular diabetes drug Actos causes bladder cancer.Actos was introduced into the market in 1999 to treat diabetes,and… Read More
The hypertension medication Benicar has been linked to increased risk of heart attack and stroke in patients with type 2 diabetes, a clinical study suggests. Now, the U.S. Food and Drug Administration (FDA) has announced a mandatory change to the drugs… Read More